PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook

Sandusky, Ohio–(Newsfile Corp. – January 14, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below:PAOG 2021 Cannabis Biopharmaceutical Strategic OutlookPAOG is a longtime participant in the cannabis sector working on initiatives…

Read More

PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow

Sandusky, Ohio–(Newsfile Corp. – January 13, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced the upcoming update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook scheduled for tomorrow, Thursday Jan 14th, 2021, will include an update on the planned PAOG stock dividend to shareholders of Puration, Inc. (OTC Pink: PURA) in conjunction with PAOG’s acquisition of…

Read More

PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021

Sandusky, Ohio–(Newsfile Corp. – January 12, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis…

Read More

Canadian Stocks to Buy: This Cannabis Stock Is Poised to Soar in 2021!

The fact that Curaleaf (TSXV:CURA) is listed on the Canadian Venture exchange means it’s perhaps less known than some of its Canadian counterparts. That said, I think this stock provides excellent leverage to the cannabis trade as it pertains to the U.S. election results. Potential legalization could help this stock skyrocket relative to its peers in the years to come. The…

Read More

PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021

Sandusky, Ohio–(Newsfile Corp. – January 11, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a…

Read More

PAOG Confirms Q4 2020 Revenue from Cannabis Asset Acquisition

Sandusky, Ohio–(Newsfile Corp. – January 8, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today confirmed that the Company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020.In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC Pink: PURA) and RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx…

Read More

Cannabis Investors: Put This Stock in Your Pipe and Smoke it

The Canadian cannabis sector is starting to see a nice rebound of late. Stocks like Canopy Growth (TSX:WEED)(NYSE:CGC) have rightly rebounded in line with other growth stocks today. Investors have become much more optimistic of late. Therefore, it’s no surprise Canopy has rebounded more than 140% from its 52-week low. Here’s why I think more upside could be on the horizon…

Read More